Richmond consumer health facility announces $54 million upgrade
RICHMOND, Va. (WRIC) — Haleon, a global consumer health company behind products like Advil, Aquafresh and Polident, announced a $54.2 million upgrade to its Richmond facility. On Monday, January 27, Gov. Glenn Youngkin (R-Va.) and Richmond Mayor Danny Avula presented the R&D facility. According to the company, the modernization will enable them to accommodate innovative technologies and expand its research capabilities. Governor Youngkin met with Haleon leadership in London in July 2024 to discuss the project. “We wanted to make sure that not just Haleon U.S, but Haleon international understood how great a future you could have here in the Commonwealth of Virginia,” Youngkin said. Along with building upgrades, Haleon and the Commonwealth are also launching a new advanced life sciences program. The five-year partnership will provide paid opportunities for undergraduate and graduate VCU students in the new pharmaceutical science degree program, as well as summer internships from all Virginia colleges. “We have a pipeline of the next generation of talent, the next generation of all of you who will be in this amazing facility delivering consumer outcomes that are so important to the health of not just Virginia, not just our nation, but candidly, the world,” Youngkin said. Mayor Danny Avula said the investment in Haleon is also a chance to showcase some of the commonwealth’s greatest talents to the world. “If we are going to be a city where every person has the opportunity to thrive and no one gets left behind, we're going to need our business community to invest here, to create jobs, here to give the amazing talent coming out of Virginia Union and University of Richmond, VCU and J. Sergeant Reynolds, the opportunity to stay here,” Avula said. According to a Haleon spokesperson, one of Haleon’s goals is to attract top talent to Richmond and further its contribution to the economic vitality of the capital – specifically helping to cultivate the area as a Life Science hub. The company did not specify when these upgrades will happen.
RICHMOND, Va. (WRIC) — Haleon, a global consumer health company behind products like Advil, Aquafresh and Polident, announced a $54.2 million upgrade to its Richmond facility.
On Monday, January 27, Gov. Glenn Youngkin (R-Va.) and Richmond Mayor Danny Avula presented the R&D facility. According to the company, the modernization will enable them to accommodate innovative technologies and expand its research capabilities.
Governor Youngkin met with Haleon leadership in London in July 2024 to discuss the project.
“We wanted to make sure that not just Haleon U.S, but Haleon international understood how great a future you could have here in the Commonwealth of Virginia,” Youngkin said.
Along with building upgrades, Haleon and the Commonwealth are also launching a new advanced life sciences program.
The five-year partnership will provide paid opportunities for undergraduate and graduate VCU students in the new pharmaceutical science degree program, as well as summer internships from all Virginia colleges.
“We have a pipeline of the next generation of talent, the next generation of all of you who will be in this amazing facility delivering consumer outcomes that are so important to the health of not just Virginia, not just our nation, but candidly, the world,” Youngkin said.
Mayor Danny Avula said the investment in Haleon is also a chance to showcase some of the commonwealth’s greatest talents to the world.
“If we are going to be a city where every person has the opportunity to thrive and no one gets left behind, we're going to need our business community to invest here, to create jobs, here to give the amazing talent coming out of Virginia Union and University of Richmond, VCU and J. Sergeant Reynolds, the opportunity to stay here,” Avula said.
According to a Haleon spokesperson, one of Haleon’s goals is to attract top talent to Richmond and further its contribution to the economic vitality of the capital – specifically helping to cultivate the area as a Life Science hub.
The company did not specify when these upgrades will happen.